| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Head Of North America
1 company
Lee Jennifer Kayden is an EVP, Head Of North America at RHYTHM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $567K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sale+OE | 2,035 | $57.22 | $116,442.70 | -25.8% | +10.1% | +77.9% | |
| Feb 13, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sell | 3,020 | $57.03 | $172,238.05 | -16.2% | -0.5% | +70.4% | |
| Feb 11, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sale+OE | 5,216 | $58.64 | $305,845.83 | -19.2% | +2.4% | +71.0% | |
| Feb 5, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sell | 3,066 | $60.55 | $185,640.20 | -40.8% | +2.8% | +70.2% | |
| Feb 4, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sale+OE | 1,447 | $59.43 | $85,995.21 | -26.4% | +7.4% | +80.1% | |
| Nov 11, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sale+OE | 66,861 | $66.33 | $4,434,882.42 | -60.2% | -10.8% | +52.3% | |
| Mar 20, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sell | 18,235 | $38.77 | $707,004.96 | -44.5% | +4.3% | +36.7% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sell | 15,515 | $39.22 | $608,498.30 | -38.2% | +5.2% | +41.1% | |
| Feb 13, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sale+OE | 1,638 | $50.80 | $83,207.19 | -10.3% | -17.8% | +17.9% | |
| Feb 1, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of North America | Sale+OE | 1,492 | $45.06 | $67,229.52 | -33.1% | -10.6% | +28.3% |